These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7156001)

  • 1. [Respiratory-tract-directed immunostimulation by a vaccine administered by the oral route].
    Menardo JL; Bousquet J; Clavel R; Coulet P; Michel FB
    Poumon Coeur; 1982; 38(5):297-300. PubMed ID: 7156001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
    Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
    Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Assessment of salivary IgA titer in children with recurrent respiratory infections treated with polyvalent oral vaccine. A controlled study].
    Cimadamore N; Agriesti G; Testa A; Borgarello R; Capo G; Crua G
    Minerva Pediatr; 1988 Jun; 40(6):355-60. PubMed ID: 3054472
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunomicrobiological monitoring of orovaccinal therapy in acute intestinal infections.
    Corridori S; Negretti F
    Dev Biol Stand; 1983; 53():285-97. PubMed ID: 6873470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [What is the purpose of mucosal antibodies? Relevance to colonization with group B streptococci].
    Hordnes K; Jonsson R; Brandtzaeg P; Haneberg B
    Tidsskr Nor Laegeforen; 1997 Nov; 117(28):4109-13. PubMed ID: 9441448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The clinical and immunological efficacy of a combination of immunoglobulins and an oral polyvalent antibacterial vaccine in recurrent respiratory infections].
    Guerra E; Papetti C; Rosso R; Visconti E; Aiuti F
    Clin Ter; 1992 Jan; 140(1):33-41. PubMed ID: 1526096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation trial of respiratory bacterial prophylaxis by a ribosomal vaccine. Multicentric double blind study.
    Fumex JP; Michel FB
    Arzneimittelforschung; 1980; 30(1a):206-13. PubMed ID: 6989376
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunomorphological determination of secretory immunoglobulin A in the bronchial mucous membrane in chronic bronchitis].
    Lutsenko MT; Tseluĭko SS; Savenko IA
    Arkh Patol; 1989; 51(7):59-63. PubMed ID: 2803044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of a polyvalent bacterial vaccine administered by aerosol in the treatment of children with respiratory infections].
    Vascotto M; Fossi E; Mancini E; Guerrini L
    Minerva Pediatr; 1985 May; 37(10):409-14. PubMed ID: 4047012
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral, inactivated, whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine: results of the initial evaluation in children. PRIDE Study Group.
    Savarino SJ; Hall ER; Bassily S; Brown FM; Youssef F; Wierzba TF; Peruski L; El-Masry NA; Safwat M; Rao M; El Mohamady H; Abu-Elyazeed R; Naficy A; Svennerholm AM; Jertborn M; Lee YJ; Clemens JD
    J Infect Dis; 1999 Jan; 179(1):107-14. PubMed ID: 9841829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of bacterial respiratory infection by an association of bacterial ribosomes and membranous proteoglycans. 2. Objective assessment of the response and of the immunological stimulation.
    Michel FB; Dussourd d'Hinterland L; Pinel AM; Guendon R; Guerrero AJ; Moutou M; Bansard JP
    Arzneimittelforschung; 1980; 30(1a):198-206. PubMed ID: 6892780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pattern of change in salivary immunoglobulins and antibodies to S. mitis and S. oralis in children undergoing bone marrow transplantation: use of an indirect method of assessment.
    Lucas V; Marchant S; Challacombe S; Roberts G; Beighton D
    Bone Marrow Transplant; 1999 Sep; 24(5):545-50. PubMed ID: 10482940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Secretory IgA and the antibacterial defenses of the respiratory tract (author's transl)].
    Michel FB; Bousquet J; Dussourd d'Hinterland L
    Bull Eur Physiopathol Respir; 1977; 13(1):27-46. PubMed ID: 402966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of antigen-specific immune responses by oral vaccination with Saccharomyces cerevisiae expressing Actinobacillus pleuropneumoniae ApxIIA.
    Shin SJ; Bae JL; Cho YW; Lee DY; Kim DH; Yang MS; Jang YS; Yoo HS
    FEMS Immunol Med Microbiol; 2005 Feb; 43(2):155-64. PubMed ID: 15681145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Secretory immunoglobulin content in the bronchial washings of children with chronic bronchopulmonary pathology].
    Livshits MB; Shterengarts BP; Stefani DV; Kapustian AM
    Vopr Okhr Materin Det; 1979; 24(3):36-41. PubMed ID: 425384
    [No Abstract]   [Full Text] [Related]  

  • 16. Vaccine-induced protection against gastrointestinal bacterial infections in the absence of secretory antibodies.
    Uren TK; Wijburg OL; Simmons C; Johansen FE; Brandtzaeg P; Strugnell RA
    Eur J Immunol; 2005 Jan; 35(1):180-8. PubMed ID: 15593123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaginal mucosal vaccine for recurrent urinary tract infections in women: results of a phase 2 clinical trial.
    Hopkins WJ; Elkahwaji J; Beierle LM; Leverson GE; Uehling DT
    J Urol; 2007 Apr; 177(4):1349-53; quiz 1591. PubMed ID: 17382730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.
    Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
    Am J Trop Med Hyg; 1994; 50(5 Suppl):42-54. PubMed ID: 8203723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunity induction (serum IgA and secretory IgA) by polyvalent vaccinal stimulation in recurrent infections of the upper respiratory tract].
    Melino C; Melino G; Poerio M
    Clin Ter; 1981 May; 97(3):229-46. PubMed ID: 7285533
    [No Abstract]   [Full Text] [Related]  

  • 20. Cellular and humoral systemic and mucosal immune responses stimulated in volunteers by an oral polybacterial immunomodulator "Dentavax".
    Petrunov B; Marinova S; Markova R; Nenkov P; Nikolaeva S; Nikolova M; Taskov H; Cvetanov J
    Int Immunopharmacol; 2006 Jul; 6(7):1181-93. PubMed ID: 16714223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.